–  Program is on track for NDA submission in 4Q 2017  –  –  OLINVO™ to be the proprietary brand name for oliceridine  – –  Company to host conference call and webcast at 8:00 a.m. EST  – Trevena, Inc. (NASDAQ: TRVN) today announced positive top-line results from its Phase 3 APOLLO-1 and APOLLO-2 pivotal efficacy studies… Continue Reading »

IRVINE, Calif., September 14, 2016 — (BUSINESS WIRE) — Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today reported the successful 90-day primary efficacy results of its 12-month Phase 3 “Mercury 1” clinical trial… Continue Reading »

Jean Brown Research participated in this study. Here is the official press release from AbbVie: NORTH CHICAGO, Ill., Feb. 10, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), announced positive top-line results from the second of two replicate pivotal Phase 3 clinical trials evaluating the efficacy and safety of Elagolix in premenopausal… Continue Reading »

Jean Brown Research participated in this study. Here is the official press release from Synergy Pharmaceuticals: NEW YORK– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as… Continue Reading »

On January 20, 2015, Denise Roberts, President of Jean Brown Research in Salt Lake City, Utah, was interviewed by Good Things Utah.  Denise talks about the importance of medical research studies.  Jean Brown Research is a stand-alone research facility that conducts phase I-IV studies (first in human through post marketing). They have been conducting clinical trials for 27… Continue Reading »

On March 24, 2014,  Denise Roberts, President of Jean Brown Research in Salt Lake City, Utah, was interviewed by Utah’s Studio 5.  Denise talks about the importance of medical research studies.  Studio 5 introduces the subject by saying, “Medical Experts are always working to find new cures for people suffering from all kinds of conditions…. Continue Reading »

The Federal Health Administration has approved a permanent implant for the first time to treat men’s urinary symptoms caused by an enlarged prostate. The FDA approved the Urolift system to improve urine flow for men 50 and older who suffer from prostate-induced urinary problems. The device improves flow by holding back prostate that pushes against… Continue Reading »